AP Newspapers, July 20, 2018. Bayer takes Essure off the market and NCHR speaks out about the need for better safety evidence for all medical devices.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Sales of Essure Birth Control Implant to Be Halted by Bayer; U.S. Last to Sell Controversial Device
Laurie McGinley, Washington Post: July 20, 2018. Bayer takes Essure off the market after many years of adverse events. NCHR President backs up this action.
Read More »Bayer Will Stop Selling the Troubled Essure Birth Control Implants
Sheila Kaplan, New York Times: July 20, 2018. Bayer Pharmaceuticals has taken Essure off the market. This birth control implant has caused startling issues.
Read More »FDA Expedited Approval Process Raises Concerns About Risks
Roxanne Nelson, FDA: July 18, 2018. Expedited approval process by the FDA for drugs raises concerns for safety of consumers.
Read More »To Improve Treatments, Researchers Want To Hunt For Clues In Medical Records
Richard Harris, NPR: July 15, 2018. While researchers consider using electronic medical records to improve treatments, NCHR president spreads caution.
Read More »